Verona Pharma
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Verona Pharma generated cash of -$50,222,000, which is more than the previous year. Cash used in financing activities reached the amount of $92,869,000 last year. Net change in cash is therefore $43,945,000.
Cash Flow
| 2014 | -5.51M | -305.65K | 20.39M |
|---|---|---|---|
| 2015 | -9.41M | -137.00K | 0 |
| 2016 | -6.89M | -50.97K | 50.83M |
| 2017 | -27.96M | -66.85M | 85.47M |
| 2018 | -22.98M | 6.70M | 1 |
| 2019 | -44.34M | 49.56M | -558.55K |
| 2020 | -45.07M | 9.71M | 192.34M |
| 2021 | -33.25M | -12K | -6.11M |
| 2022 | -59.86M | -29K | 140.81M |
| 2023 | -50.22M | 0 | 92.86M |
VRNA Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 227.82M | 148.38M | 187.98M | 30.42M | 25.94M | 39.89M | 53.76M | 4.34M | 14.77M | 939.78K |
Operating activities | ||||||||||
Net income | -54.57M | -68.70M | -55.56M | -65.14M | -51.40M | -30.62M | -34.05M | -7.36M | -13.29M | -5.90M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 116K | 636K | 629K | 623K | 660.82K | 124.35K | 166.22K | 76.02K | 78.69K | 82.43K |
Stock-based compensation expense | 19.01M | 14.12M | 25.42M | 22.17M | 3.20M | 0 | 3.94M | 710.54K | 591.03K | 299.13K |
| Deferred income tax benefit | 19.01M | 14.12M | 25.42M | 22.17M | 3.20M | 0 | 3.94M | 710.54K | 591.03K | 299.13K |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 0 | 3.96M | -6.92M | 773.97K | -3.94M | 0 | -161K | 0 | 0 | 0 |
Inventories | 0 | -3.96M | 6.92M | -773.97K | 4.24M | 0 | 0 | 0 | 0 | 0 |
Accounts payable | 486K | -7.14M | 9.86M | -1.39M | -1.74M | 0 | 0 | 0 | 0 | 0 |
Cash generated by operating activities | -50.22M | -59.86M | -33.25M | -45.07M | -44.34M | -22.98M | -27.96M | -6.89M | -9.41M | -5.51M |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | -10.41M | -75.75M | -73.60M | 0 | 0 | 0 |
Investments In Property Plant And Equipment | 0 | -29K | -12K | -82K | -369.74K | -340.06K | -293.25K | -157.75K | -211.95K | -343.29K |
Acquisitions Net | 0 | 0 | 0 | 0 | 319.92K | 323.57K | 49.36M | 0 | 0 | 0 |
Cash generated by investing activities | 0 | -29K | -12K | 9.71M | 49.56M | 6.70M | -66.85M | -50.97K | -137.00K | -305.65K |
Financing activities | ||||||||||
Common Stock Issued | 56.90M | 149.79M | 733K | 200.15M | 0 | 0 | 94.64M | 55.21M | 0 | 20.39M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | -5.06M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 38.70M | 5M | 0 | -4.93M | 0 | 0 | 0 | 0 | 0 | 0 |
Cash used in financing activities | 92.86M | 140.81M | -6.11M | 192.34M | -558.55K | 1 | 85.47M | 50.83M | 0 | 20.39M |
Net Change In Cash | 43.94M | 79.44M | -39.60M | 157.55M | 4.13M | -14.79M | -11.27M | 44.73M | -9.54M | 14.57M |
Cash at end of period | 271.77M | 227.82M | 148.38M | 187.98M | 30.07M | 25.10M | 42.49M | 49.08M | 5.22M | 15.51M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source |